Abstract
The effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on acetyl-CoA carboxylase (ACC) activity and synthesis was examined. Male Wistar rats received a singlei. p. injection of TCDD (53 μg/kg), and nine days later body weight, liver weight, hepatic lipid, ACC activity and mass were determined and compared to pair-fed controls. Body weights of TCDD-treated animals decreased, while liver weights increased resulting in an increase in liver to body weight ratios. ACC activity was decreased by 65%, however sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and Western analysis using a biotin specific probe revealed that ACC protein levels were not appreciably changed. In addition, there was a large increase in exogenous lipid material in TCDD-treated livers as determined by osmium tetroxide staining. These data suggest that the decrease in ACC activity may be due to direct inhibition of the enzyme by negative allosteric interactions with free fatty acids released from adipose tissue that subsequently accumulate in liver.
Similar content being viewed by others
Abbreviations
- ACC:
-
acetyl-CoA carboxylase
- FAS:
-
fatty acid synthase
- MPO:
-
1-methyl-2-pyrrolidinone
- PC:
-
pyrivate carboxylase
- SDS-PAGE:
-
sodium dodecyl sulfate-polyacrylamide gel electrophoresis
- TCDD:
-
2,3,7,8-tetrachlorodibenzo-p-dioxin
References
Hodgson, E., and Levi, P.E. (1987)A Textbook of Modern Toxicology, p. 212, Elsevier, New York.
Murphy, S.D. (1986)Toxicology: The Basic Science of Poisons (Klaassen, C.D., Amdur, M.O., and Doull, J.D., eds.), pp. 554–555 Macmillan Publishing Co., New York.
Wagner, S.L. (1983) inClinical Toxicology of Agricultural Chemicals, pp. 138–155, Noyes Data Corp., Park Ridge.
Neal, R.A., Beatty, P.W., and Gasiewicz, T.A. (1979)Drug. Met. Rev. 13, 1315.
Poland, A., and Knutson, J.C. (1982)Ann. Rev. Pharmacol. Toxicol. 22, 517–554.
Potter, C.L., Sipes, I.G., and Russell, D.H. (1983)Toxicol. Appl. Pharmacol. 69, 89–95.
Rozman, K., Rozman, R., and Greim, H. (1984)Toxicol. Appl. Pharmacol. 72, 372–376.
Rozman, K., and Greim, H. (1986)Arch. Toxicol. 59, 211–215.
Potter, C.L., Moore, R.W., Inhorn, S.L., Hagen, T.C., and Peterson, R.E. (1986)Toxicol. Appl. Pharmacol. 84, 45–55.
Gorski, J.R., and Rozman, K. (1987)Toxicology 44, 297–307.
Muzi, G., Gorski, J.R., and Rozman, K. (1987)Arch. Toxicol. 61, 34–39.
Romkes, M., Piskorska-Pliszczynska, J., and Safe, S. (1987)Toxicol. Appl. Pharmacol. 87, 306–314.
McConkey, D.J., Hartzell, P., Duddy, S.K., Hakansson, H., and Orrenius, S. (1988)Science 242, 256–258.
Wahba, Z.Z., Lawson, T.A., and Stohs, S.J. (1988)Cancer Lett. 29, 281–286.
Ganong, W.F. (1983) inReview of Medical Physiology, pp. 221–253, Lange.
Rozman, K., Ernst, S.W., and Weber, L.W.D. (1989)The Toxicologist. 9, 118.
Lakshman, M.R., Campbell, B.S., Chirtel, S.J., and Ekarohita, N. (1988)Lipids 23, 904–906.
Gorski, J.R., Weber, L.W.D., and Rozman, K. (1988)Arch. Toxicol. 62, 146–151.
Goodridge, A.G., Back, D.W., Wilson, S.B., and Goldman, M.J. (1988)Ann. N.Y. Acad. Sci. 478, 46–62.
Freytag, S.O., and Collier, K.J. (1984)J. Biol. Chem. 259, 12831–12837.
Wakil, S.J. (1988)Ann. N.Y. Acad. Sci. 478, 203–219.
Roth, W., Voorman, R., and Aust, S.D. (1988)Toxicol. Appl. Pharmacol. 92, 65–74.
Burton, J.D., Gronwald, J.W., Somers, D.A., Connelly, J.A., Gengenbach, B.G., and Wyse, D.L. (1987)Biochem. Biophys. Res. Commun. 148, 1039–1044.
Harwood, J.L. (1988)TIBS 13, 330–331.
Secor, J., and Cseke, C. (1988)Plant Physiol. 86, 10–12.
Lakshman, M.R., Chirtel, S.J., Chambers, L.L., and Coutlakis, P.J. (1989)J. Pharmacol. Exp. Ther. 248, 62–66.
Witteres, L.A., and Vogt, B. (1981)J. Lipid Res. 22, 364–369.
Mallory, F.B. (1961)Pathological Technique, pp. 118–120, Hafner Publishing Co., New York.
McKim, Jr., J.M., Schaup, H.W., Marien, K., and Selivonchick, D.P. (1989)Lipids 24, 187–192.
Allred, J.B., and Roehrig, K.L. (1978)J. Biol. Chem. 253, 4826–4829.
Ballard, F.J., and Hanson, R.W. (1967)Biochem. J. 104, 866–871.
Hames, B.J. (1981)Gel Electrophoresis of Proteins: A Practical Approach (Hames, B.D., and Rickwood, D., eds.) pp. 26–27, IRL Press, Oxford.
Swift, L.L., Gasiewicz, T.A., Dunn, G.D., Soule, P.D., and Neal, R.A. (1981)Toxicol. Appl. Pharmacol. 59, 489–499.
Hardie, D.G., and Cohen, P. (1978)J. Biochem. 92, 25–34.
Haystead, T.A.J., and Hardie, D.G. (1986)J. Biochem. 234, 279–284.
Albro, P.W., Corbett, J.T., Harris, M., and Lawson, L.D. (1978)Chem. Biol. Inter. 23, 315–330.
Goodridge, A.G. (1985) inBiochemistry of Lipids and Membranes (Vance, D.E., and Vance, J.E., eds.) pp. 143–180, The Benjamin/Cummings Pub. Co., Menlo Park.
Towle, H.C., and Mariash, C.N. (1986)Fed. Proc. 45, 2406–2411.
Goodridge, A.G. (1986)Fed. Proc. 45, 2399–2405.
Lebofsky, M., Weber, L.W.D., Greim, H., and Rozman, K. (1989)The Toxicologist 9, 118.
Thampy, K.G., and Wakil, S.J. (1988)J. Biol. Chem. 263, 6447–6453.
Thampy, K.G., and Wakil, S.J. (1988)J. Biol. Chem. 263, 6454–6458.
Hardie, D.G., Carling, D., and Sim, A.T.R. (1989)TIBS 14, 20–23.
Carling, D., Zammit, V.A., and Hardie, D.G. (1987)FEBS Lett. 223, 217–222.
Author information
Authors and Affiliations
About this article
Cite this article
McKim, J.M., Marien, K., Schaup, H.W. et al. Alterations of hepatic acetyl-CoA carboxylase by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Lipids 26, 521–525 (1991). https://doi.org/10.1007/BF02536597
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02536597